Nicotine reverses anhedonic-like response and cognitive impairment in the rat chronic mild stress model of depression: Comparison with sertraline

Journal of Psychopharmacology

Volumn 25, Issue 8, 2011, Pages 1134-1141

  Andreasen, Jesper T ^a,b   Henningsen, Kim ^a   Bate, Simon ^c   Christiansen, Sofie ^a   Wiborg, Ove ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c HUNTINGDON LIFE SCIENCES   (United Kingdom)

Author keywords

Anhedonia; antidepressants; behaviour; chronic mild stress; cognition; nicotine; rats

Indexed keywords

NICOTINE; SERTRALINE; SUCROSE;

ANHEDONIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; CHRONIC STRESS; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DISEASE MODEL; DRUG POTENTIATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SUGAR INTAKE;

ANHEDONIA; ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; COGNITION DISORDERS; DEPRESSION; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; MALE; NICOTINE; NICOTINIC AGONISTS; RATS; RATS, WISTAR; SERTRALINE; STRESS, PSYCHOLOGICAL; SUCROSE;

EID: 80052014049     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881110391831     Document Type: Review

References (50)

1. Amado-Boccara I, Gougoulis N, Poirier Littre MF, Galinowski A, Loo H. Effects of antidepressants on cognitive functions: a review. Neurosci Biobehav Rev. 1995 ; 19: 479-493
2. Andreasen JT, Olsen GM, Wiborg O, Redrobe JP. Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests. J Psychopharmacol. 2009a ; 23: 797-804
3. Andreasen JT, Nielsen EO, Redrobe JP. Chronic oral nicotine increases brain [(3)H]epibatidine binding and responsiveness to antidepressant drugs, but not nicotine, in the mouse forced swim test. Psychopharmacology (Berl). 2009b ; 205: 517-528
4. Andreasen JT, Redrobe JP. Antidepressant-like effects of nicotine and mecamylamine in the mouse forced swim and tail suspension tests: role of strain, test and sex. Behav Pharmacol. 2009a ; 20: 286-295
5. Andreasen JT, Redrobe JP. Nicotine, but not mecamylamine, enhances antidepressant-like effects of citalopram and reboxetine in the mouse forced swim and tail suspension tests. Behav Brain Res. 2009b ; 197: 150-156
6. Andreasen JT, Nielsen EO, Christensen JK, Olsen GM, Peters D, Mirza NR, et al. (2010) Subtype-selective nicotinic acetylcholine receptor agonists enhance the responsiveness to citalopram and reboxetine in the mouse forced swim test. J Psychopharmacol 00: 1-10 (accessed 30 November 2010).
7. Bisgaard CF, Jayatissa MN, Enghild JJ, Sanchez C, Artemychyn R, Wiborg O. Proteomic investigation of the ventral rat hippocampus links DRP-2 to escitalopram treatment resistance and SNAP to stress resilience in the chronic mild stress model of depression. J Mol Neurosci. 2007 ; 32: 132-144 (Pubitemid 47460449)
8. Bondi CO, Rodriguez G, Gould GG, Frazer A, Morilak DA. Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment. Neuropsychopharmacology. 2008 ; 33: 320-331 (Pubitemid 350243351)
9. Breslau N. Psychiatric comorbidity of smoking and nicotine dependence. Behav Genet. 1995 ; 25: 95-101
10. Caldarone BJ, Harrist A, Cleary MA, Beech RD, King SL, Picciotto MR. High-affinity nicotinic acetylcholine receptors are required for antidepressant effects of amitriptyline on behavior and hippocampal cell proliferation. Biol Psychiatry. 2004 ; 56: 657-664 (Pubitemid 39446847)
11. Castaneda AE, Tuulio-Henriksson A, Marttunen M, Suvisaari J, Lonnqvist J. A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults. J Affect Disord. 2008 ; 106: 1-27 (Pubitemid 350309672)
12. Covey LS, Glassman AH, Stetner F. Major depression following smoking cessation. Am J Psychiatry. 1997 ; 154: 263-265 (Pubitemid 27053736)
13. Cryan JF, Valentino RJ, Lucki I. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev. 2005 ; 29: 547-569 (Pubitemid 40755456)
14. Djuric VJ, Dunn E, Overstreet DH, Dragomir A, Steiner M. Antidepressant effect of ingested nicotine in female rats of Flinders resistant and sensitive lines. Physiol Behav. 1999 ; 67: 533-537 (Pubitemid 29488531)
15. Diagnostic and Statistical Manual of Mental Disorders IV-TR. Washington, DC: American Psychiatric Press ; 2000 :
16. Elizalde N, Gil-Bea FJ, Ramirez MJ, Aisa B, Lasheras B, Del Rio J, et al. Long-lasting behavioral effects and recognition memory deficit induced by chronic mild stress in mice: effect of antidepressant treatment. Psychopharmacology (Berl). 2008 ; 199: 1-14
17. George TP, Sacco KA, Vessicchio JC, Weinberger AH, Shytle RD. Nicotinic antagonist augmentation of selective serotonin reuptake inhibitor-refractory major depressive disorder: a preliminary study. J Clin Psychopharmacol. 2008 ; 28: 340-344
18. Glassman AH, Helzer JE, Covey LS, Cottler LB, Stetner F, Tipp JE, et al. Smoking, smoking cessation, and major depression. JAMA. 1990 ; 264: 1546-1549 (Pubitemid 20303384)
19. Harrison AA, Gasparini F, Markou A. Nicotine potentiation of brain stimulation reward reversed by DH beta E and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats. Psychopharmacology (Berl). 2002 ; 160: 56-66 (Pubitemid 34169826)
20. Henningsen K, Andreasen JT, Bouzinova EV, Jayatissa MN, Jensen MS, Redrobe JP, et al. Cognitive deficits in the rat chronic mild stress model for depression: relation to anhedonic-like responses. Behav Brain Res. 2009 ; 198: 136-141
21. Herrmann LL, Goodwin GM, Ebmeier KP. The cognitive neuropsychology of depression in the elderly. Psychol Med. 2007 ; 37: 1693-1702 (Pubitemid 350100441)
22. Hughes RN. The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory. Neurosci Biobehav Rev. 2004 ; 28: 497-505 (Pubitemid 39311449)
23. Hughes RN. Neotic preferences in laboratory rodents: issues, assessment and substrates. Neurosci Biobehav Rev. 2007 ; 31: 441-464
24. Jayatissa MN, Bisgaard CF, West MJ, Wiborg O. The number of granule cells in rat hippocampus is reduced after chronic mild stress and re-established after chronic escitalopram treatment. Neuropharmacology. 2008 ; 54: 530-541
25. Kenny PJ, Markou A. Nicotine self-administration acutely activates brain reward systems and induces a long-lasting increase in reward sensitivity. Neuropsychopharmacology. 2006 ; 31: 1203-1211 (Pubitemid 43971837)
26. Lalonde R. The neurobiological basis of spontaneous alternation. Neurosci Biobehav Rev. 2002 ; 26: 91-104 (Pubitemid 34130537)
27. Lapiz-Bluhm MD, Soto-Pina AE, Hensler JG, Morilak DA. Chronic intermittent cold stress and serotonin depletion induce deficits of reversal learning in an attentional set-shifting test in rats. Psychopharmacology (Berl). 2009 ; 202: 329-341
28. Levin ED, McClernon FJ, Rezvani AH. Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berl). 2006 ; 184: 523-539 (Pubitemid 43255869)
29. Lippiello PM, Beaver JS, Gatto GJ, James JW, Jordan KG, Traina VM, et al. TC-5214 (S-( + )-mecamylamine): a neuronal nicotinic receptor modulator with antidepressant activity. CNS Neurosci Ther. 2008 ; 14: 266-277
30. Marona-Lewicka D, Nichols DE. The Effect of Selective Serotonin Releasing Agents in the Chronic Mild Stress Model of Depression in Rats. Stress. 1997 ; 2: 91-100
31. Matta SG, Balfour DJ, Benowitz NL, Boyd RT, Buccafusco JJ, Caggiula AR, et al. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berl). 2007 ; 190: 269-319 (Pubitemid 46156883)
32. McClernon FJ, Hiott FB, Westman EC, Rose JE, Levin ED. Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial. Psychopharmacology (Berl). 2006 ; 189: 125-133 (Pubitemid 44607266)
33. Mitchell SN. Role of the locus coeruleus in the noradrenergic response to a systemic administration of nicotine. Neuropharmacology. 1993 ; 32: 937-949 (Pubitemid 23316500)
34. Newhouse PA, Potter A, Singh A. Effects of nicotinic stimulation on cognitive performance. Curr Opin Pharmacol. 2004 ; 4: 36-46 (Pubitemid 38145836)
35. Nowakowska E, Kus K, Florek E, Czubak A, Jodynis-Liebert J. The influence of tobacco smoke and nicotine on antidepressant and memory-improving effects of venlafaxine. Hum Exp Toxicol. 2006 ; 25: 199-209
36. Papp M, Nalepa I, Antkiewicz-Michaluk L, Sanchez C. Behavioural and biochemical studies of citalopram and WAY 100635 in rat chronic mild stress model. Pharmacol Biochem Behav. 2002 ; 72: 465-474 (Pubitemid 34251360)
37. Popik P, Kozela E, Krawczyk M. Nicotine and nicotinic receptor antagonists potentiate the antidepressant-like effects of imipramine and citalopram. Br J Pharmacol. 2003 ; 139: 1196-1202 (Pubitemid 36920683)
38. Porsolt RD, Anton G, Blavet N, Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol. 1978 ; 47: 379-391
39. Rabenstein RL, Caldarone BJ, Picciotto MR. The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not beta2- or alpha7-nicotinic acetylcholine receptor subunit knockout mice. Psychopharmacology (Berl). 2006 ; 189: 395-401 (Pubitemid 44772820)
40. Ribeiro EB, Bettiker RL, Bogdanov M, Wurtman RJ. Effects of systemic nicotine on serotonin release in rat brain. Brain Res. 1993 ; 621: 311-318 (Pubitemid 23248092)
41. Rice ME, Cragg SJ. Nicotine amplifies reward-related dopamine signals in striatum. Nat Neurosci. 2004 ; 7: 583-584 (Pubitemid 38691894)
42. Rollema H, Guanowsky V, Mineur YS, Shrikhande A, Coe JW, Seymour PA, et al. Varenicline has antidepressant-like activity in the forced swim test and augments sertraline's effect. Eur J Pharmacol. 2009 ; 605: 114-116
43. Rosenzweig-Lipson S, Beyer CE, Hughes ZA, Khawaja X, Rajarao SJ, Malberg JE, et al. Differentiating antidepressants of the future: efficacy and safety. Pharmacol Ther. 2007 ; 113: 134-153 (Pubitemid 46017069)
44. Semba J, Mataki C, Yamada S, Nankai M, Toru M. Antidepressantlike effects of chronic nicotine on learned helplessness paradigm in rats. Biol Psychiatry. 1998 ; 43: 389-391 (Pubitemid 28139460)
45. Song L, Che W, Min-Wei W, Murakami Y, Matsumoto K. Impairment of the spatial learning and memory induced by learned helplessness and chronic mild stress. Pharmacol Biochem Behav. 2006 ; 83: 186-193
46. Tizabi Y, Getachew B, Rezvani AH, Hauser SR, Overstreet DH. Antidepressant-like effects of nicotine and reduced nicotinic receptor binding in the fawn-hooded rat, an animal model of co-morbid depression and alcoholism. Prog Neuropsychopharmacol Biol Psychiatry. 2009 ; 33: 398-402
47. Tizabi Y, Overstreet DH, Rezvani AH, Louis VA, Clark E, Janowsky DS, et al. Antidepressant effects of nicotine in an animal model of depression. Psychopharmacology (Berl). 1999 ; 142: 193-199 (Pubitemid 29190855)
48. Ueno K, Togashi H, Matsumoto M, Ohashi S, Saito H, Yoshioka M. Alpha4beta2 nicotinic acetylcholine receptor activation ameliorates impairment of spontaneous alternation behavior in stroke-prone spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder. J Pharmacol Exp Ther. 2002 ; 302: 95-100 (Pubitemid 34680426)
49. Vazquez-Palacios G, Bonilla-Jaime H, Velazquez-Moctezuma J. Antidepressant effects of nicotine and fluoxetine in an animal model of depression induced by neonatal treatment with clomipramine. Prog Neuropsychopharmacol Biol Psychiatry. 2005 ; 29: 39-46 (Pubitemid 40018203)
50. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology. 2005 ; 52: 90-110 (Pubitemid 41160326)